PKR-NF-κB Pathway Upstream of IFN-β Induction Is Dysregulated in Oncolytic Sindbis Virus-infected HeLa Cells

Xue Ma1, Tomoko Ogawa1, Zheng Tian1

  • 1Department of Molecular Virology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Anticancer Research
|June 23, 2023
PubMed
Abstract

Insights

Sindbis virus (SINV) effectively infects cancer cells, causing apoptosis. Dysregulation of protein kinase R (PKR) in cancer cells determines the oncolytic effect of SINV, making it a promising cancer therapy.

Area of Science:

  • Virology
  • Cancer Biology
  • Immunology

Background:

  • Sindbis virus (SINV) is a naturally occurring oncolytic virus with selective toxicity towards cancer cells.
  • Recombinant SINV expressing fluorescent proteins enables precise analysis of viral infection and replication dynamics.

Purpose of the Study:

  • To precisely analyze the infection and replication of a recombinant Sindbis virus (SINV) in both cancerous and normal cells.
  • To investigate the antiviral responses in cancer cells versus normal cells upon SINV infection.

Main Methods:

  • Analysis of antiviral responses, including Interferon-beta (IFN-β) mRNA, protein kinase R (PKR), Nuclear Factor-kappa B (NF-κB), and caspase 3/7.
  • Comparative study of SINV infection in cancerous HeLa cells and normal human fibroblast TIG-1-20 cells.

Main Results:

  • SINV infected, replicated, and proliferated in both HeLa and TIG-1-20 cells, but caused lytic infection and apoptosis exclusively in HeLa cells.
  • IFN-β mRNA expression was suppressed in SINV-infected HeLa cells compared to TIG-1-20 cells.
  • Compromised PKR and NF-κB pathway activation in early infection of HeLa cells correlated with suppressed IFN induction.

Conclusions:

  • The dysregulation of protein kinase R (PKR) in HeLa cells is the key determinant for Sindbis virus (SINV) oncolysis.
  • SINV demonstrates potential as an oncolytic agent due to its preferential replication and induction of apoptosis in cancer cells.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K